OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the OptiNose's Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Optinose Inc. (OPTN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Great Point Partners Jeffrey Jay And David Kroin | 7,894,736 | $14,605,262 | 2.86% | |
| 2. | Velan Capital Adam Morgan | 3,496,861 | $6,469,193 | +61% | 5.71% |
| 3. | Kingdon Capital Mark Kingdon | 3,149,237 | $5,826,088 | +37% | 1.16% |
| 4. | Armistice Capital Steven Boyd | 1,996,491 | $3,693,508 | 0.06% | |
| 5. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,450,000 | $2,682,500 | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.06 | 34,000 | Officer | 142,278 | 2021-05-20 | Filing | |
| $2.99 | 10,000 | Director | 31,230 | 2021-05-10 | Filing | |
| $3.91 | 11,742 | Officer, Director | 636,955 | 2021-03-18 | Filing | |
| $3.85 | 787 | Officer, Director | 625,213 | 2021-03-17 | Filing | |
| $3.90 | 2,500 | Officer | 9,751 | 2020-09-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.79 | 4,972 | Officer | 333,573 | 2023-03-16 | Filing | |
| $1.79 | 11,040 | Officer, Director | 517,128 | 2023-03-16 | Filing | |
| $1.77 | 5,241 | Officer | 180,353 | 2023-01-13 | Filing | |
| $0.00 | 8,148 | Officer | 185,920 | 2023-01-13 | Filing | |
| $1.77 | 29,664 | Officer, Director | 853,384 | 2023-01-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 14,661,111 | $27,123,055 | 0% | |
| 2. | 14,605,263 | $26,800,658 | 9.13% | |
| 3. | 4,045,132 | $7,483,494 | 1.62% | |
| 4. | 3,146,220 | $5,820,507 | 0% | |
| 5. | 2,875,580 | $5,319,823 | 0% |
News See All
OptiNose, Inc. (NASDAQ:OPTN) Q3 2022 Earnings Call Transcript
Jonathan Neely: Third quarter 2022 performance and our plans for the remainder of the year. I'm joined today by our CEO, Peter Miller; our President and Chief Operating Officer, Dr.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.
5 Unknown Biotech Stocks That Can Explode in 2022
In this article, we discuss the 5 unknown biotech stocks that can explode in 2022.
Is OPTN A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About OptiNose, Inc. (OPTN)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been This Bullish On OptiNose, Inc. (OPTN)
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Hedge Funds Have Never Been More Bullish On OptiNose, Inc. (OPTN)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is OptiNose, Inc. (NASDAQ:OPTN) A Good Stock To Buy?
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...
Billionaire Hedge Funds
